(Bloomberg) — Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.
Most Read from Bloomberg
A deal for Summit Partners-backed VaxCare could be announced within weeks, said the people, who asked not to be identified because because the information is private. A final agreement hasn’t been reached and talks could still end without one, the people said.
Orlando-based VaxCare offers a platform for medical practices and health systems to manage inventory, billing and tracking for vaccines and contraceptive devices, according to its website.
Private equity firm Summit invested in VaxCare in 2020. Other investors include Echo Health Ventures and HLM Investment Partners, according to data provider PitchBook.
A spokesperson for Blackstone declined to comment. Representatives for VaxCare, Summit, Echo Health and HLM didn’t immediately respond to requests for comment.
Most Read from Bloomberg Businessweek
©2025 Bloomberg L.P.
